Release date: 2010-09-27
Recently, the 2010 National Maternal and Child Health Hotspot Forum was held in Guangzhou. Cheng Jing, an academician of the Chinese Academy of Engineering, said that the genetic testing chip for the "endemic disease" thalassemia in Guangdong is expected to be available next year.
In recent years, the birth defect rate of newborns in China has continued to rise, with Guangdong reaching 2.7%. Cheng Jing revealed that the biochip Beijing National Engineering Research Center birth defect sub-center will be located in the Guangdong Maternal and Child Health Hospital, and will cooperate with Guangdong to develop bio-chips.
Guangdong is a province with high incidence of thalassemia, with about 10% to 15% of people carrying thalassaemia genes. If both couples carry the thalassemia gene, the chance of having a 1/4 chance of having a child is a severe thalassemia patient. Yin Aihua, deputy director of the Pregnancy and Pregnancy Center of the Pregnancy and Pregnancy Center of the Provincial Maternal and Child Health Hospital, revealed that in order to reduce the birth defects of newborns, he has cooperated with Academician Cheng Jing to develop a genetic testing chip for thalassaemia, which is expected to be available next year.
It is understood that the current detection kit for the thalassemia gene is troublesome, and there are more than 20 steps that are manual operations, which are prone to misdiagnosis, and are not limited to technical problems at county hospitals. If the thalassemia gene chip is successfully developed, it can be tested in large quantities. The daily detection volume of the hospital can be increased from the current 100 specimens to tens of thousands of specimens, and the testing cost will be much cheaper.
Since last year, the research team led by Cheng Jing has independently developed four new types of genetic deafness detection gene chip, mycobacterial species identification gene chip, Mycobacterium tuberculosis drug resistance detection gene chip, and autoimmune disease detection protein chip. Disease detection products. At present, they are all in clinical use, and many Guangdong hospitals such as Guangdong Maternal and Child Health Hospital have been tested.
Source: Medicare
BPAP20 AUTO / BPAP25 AUTO is a professional solution for OSA patient who have trouble tolerating CPAP device.
4.3-inch TFT Color LCD Screen, Displaying A Number Of Monitored Parameters; Respiration Pressure, Flow Rate Waveform Display, Clear And Accurate; Smart Start And Stop Breathing; Multiple Alarm Functions; Intelligent Automatic Leak Compensation. The New Integrated Heated Humidifier, According To The Different Needs Of Patients, Set Up Multiple Profiles Of Temperature And Humidity, Multiple Anti-Reflux Design, Safe To Use. Built-In High-Capacity Smart Card Can Be Used For Data Recording, The Recording Time, Respiratory Status, Can Assess The Therapeutic Effect, And Print Reports.
BPAP 20 Auto,BPAP 25 Auto,Non Invasive Ventilation Hood,Non Invasive Ventilation Oxygen
Shenyang RMS MEDICAL TECH CO.,LTD , https://www.medicalrms.com